Although low in numbers, Foxp3+ Treg cells remained functional in NARA1leukin-treated animals; thus, the depletion of Treg cells in Foxp3DTR mice by using diphtheria toxin synergized with NARA1leukin therapy to further improve tumor control (Supplementary Fig. 2). This evidence concerns the gene FOXP3 and neoplasm.